CANCER WAITING TARGETS – A GUIDE FOR WALES

(standardised definitions of breast cancer clinical trial end points) in that the APHINITY trial excluded second primary non-breast cancers. While this can affect effectiveness estimates, it did not appear to affect the results when comparing outcomes that included and did not include non-breast cancers in the APHINTY trial (pp4124-4125 of CSR ... ................
................